IC
PBYI icon

IEQ Capital’s Puma Biotechnology PBYI Stock Holding History

IEQ Capital’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$95.2K Buy
14,901
+3,406
+30% +$22K ﹤0.01% 1802
2025
Q4 		$68.4K Buy
+11,495
New +$61K ﹤0.01% 1792
2025
Q3 		– Sell
-14,305
Closed -$49.1K – 2019
2025
Q2 		$49.1K Buy
+14,305
New +$45.7K ﹤0.01% 1765

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

IEQ Capital's PBYI Position: Q1 2026 in Review

IEQ Capital increased its Puma Biotechnology (PBYI) stake by 30% in Q1 2026, buying an estimated $22K and bringing the position to 14,901 shares worth $95.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1802.

IEQ Capital first reported a position in PBYI in Q2 2025 and has held it in 3 quarters since. 157 funds tracked by Wall St. Rank hold PBYI as of Q1 2026.

  • IEQ Capital held 14,901 shares of Puma Biotechnology worth $95.2K as of Q1 2026.
  • IEQ Capital bought 3,406 Puma Biotechnology shares in Q1 2026, an estimated $22K.
  • Puma Biotechnology made up ﹤0.01% of IEQ Capital's portfolio in Q1 2026, its #1802 holding.
  • IEQ Capital first reported a position in Puma Biotechnology in Q2 2025 and has held it in 3 quarters since.
  • 157 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.